TB-500/BPC-157 10 MG
Dual-peptide research blend studied in preclinical laboratory settings
For research purposes only. Not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
Frequently Bought Together
Dual Peptide Research Kit
TB-500/BPC-157 blend plus the required bacteriostatic diluent.
Extended Research Panel
Combine with Semax for a broader multi-pathway preclinical investigation.
About This Research Compound
A combination of TB-500 (Thymosin Beta-4 fragment) and BPC-157 (Body Protection Compound-157), studied in preclinical research for their interactions with cellular signaling pathways. Both peptides are subjects of ongoing laboratory investigation. For research purposes only. Not for human consumption.
Compound Specifications
What is this blend?
This vial contains a 1:1 blend of TB-500 (a Thymosin Beta-4 fragment) and BPC-157 (Body Protection Compound-157). Both peptides have been independently studied in preclinical research for their interactions with cellular signaling pathways.
Form & Presentation
Supplied as a co-lyophilized powder containing 5mg TB-500 and 5mg BPC-157 per vial. Both compounds are HPLC-verified to ≥99% purity each.
Storage Requirements
Store lyophilized blend at -20°C. After reconstitution with BAC Water, refrigerate at 2–8°C and use within 4–6 weeks. Avoid light and repeat freeze-thaw cycles.
Cytoskeletal Research (TB-500)
TB-500 (Thymosin Beta-4 fragment) has been studied for its interactions with actin polymerization and cytoskeletal organization in preclinical cell models.
Angiogenesis Models (TB-500)
Preclinical research has used TB-500 to investigate effects on endothelial cell migration and tube formation in in vitro angiogenesis assays.
Cytoprotective Pathways (BPC-157)
BPC-157 has been studied in gastric and intestinal cell models for its interactions with cytoprotective signaling, including NO synthesis and growth factor receptor pathways.
What is TB-500 and what has it been studied for?
TB-500 is a synthetic peptide based on a fragment of Thymosin Beta-4, a naturally occurring protein. It has been studied in preclinical research for its interactions with cellular cytoskeletal signaling pathways. All referenced findings are from preclinical studies. It is not approved for human use.
What is BPC-157 and what research exists on it?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide studied independently in preclinical research for its interactions with cellular signaling pathways. It is not approved for human or veterinary therapeutic use and is sold for laboratory research only.
Why are TB-500 and BPC-157 offered together?
TB-500 and BPC-157 are often studied in combination in research settings as investigators hypothesize complementary interactions. The 10mg blend (5mg each) allows researchers to study both compounds within a single reconstituted solution.
What purity is the TB-500/BPC-157 blend?
Both peptides in our blend are verified via HPLC and mass spectrometry to a minimum of 99%+ purity each. Certificate of Analysis documentation is available on request.
Customer Reviews
Consistently high quality
Third order now. Reliability and quality are always there. Packaging is excellent and keeps the peptides stable.
Top tier healing peptides
Used for injury recovery research. Results were remarkable. Highly recommend Peptide Perfection for anyone researching these compounds.
Synergistic effects are real
Both compounds individually are great but together the effects are amplified. Very happy with quality and fast shipping.
Best recovery peptide combination
The TB-500/BPC-157 blend is phenomenal. Recovery research has never been more exciting. Peptide Perfection consistently delivers excellent purity. My go-to supplier.
You May Also Like
Semax
Synthetic neuropeptide analogue for in vitro research
MOTS-c
Mitochondria-derived peptide for metabolic research
GHK-Cu
Copper-binding tripeptide for laboratory research
Retatrutide
Triple receptor agonist for metabolic research
TB-500/BPC-157
$60.00